U.S. Food and Staples Retail Stock News

NYSE:RLJ
NYSE:RLJHotel and Resort REITs

Does RLJ Lodging Trust’s (RLJ) Steady Dividend Policy Reveal Its True Capital Allocation Priorities?

RLJ Lodging Trust recently declared a quarterly cash dividend of US$0.15 per common share and US$0.4875 per Series A Preferred Share, both payable in July 2026 to shareholders of record as of June 30, 2026. These dividend declarations highlight the REIT’s ongoing capital return to both common and preferred investors, complementing analyst views that focus on its operating performance and valuation profile. Against this backdrop of continued dividend payments, we’ll examine how RLJ’s recent...
NYSE:PLD
NYSE:PLDIndustrial REITs

What Prologis (PLD)'s Analyst Optimism and Data Center Push Means For Shareholders

In recent days, analysts have become more optimistic about Prologis, with brokerage ratings and the Zacks Rank reflecting improving earnings expectations ahead of its July 16, 2026, results. At the same time, Prologis’ push into data center development, leveraging its logistics footprint and access to power, is emerging as a potentially important new revenue pillar tied to AI-related infrastructure demand. We’ll now examine how growing analyst optimism around earnings and the company’s...
NYSE:AWR
NYSE:AWRWater Utilities

Is AWR’s Completed Equity Program And Issuance Pause Through 2029 Altering The Investment Case For American States Water?

American States Water Company has completed a US$200 million at-the-market follow-on equity offering of common shares, issuing multiple tranches at varying prices to fully utilize its authorized program. An interesting aspect of the announcement is management’s indication that no additional equity issuance is planned through 2029, providing investors with clearer visibility on potential dilution. We’ll now examine how the completed equity program and stated pause on new issuance shape...
NYSE:BF.B
NYSE:BF.BBeverage

Did Brown-Forman's (BF.B) Revenue Slip and EBITDA Miss Just Reframe Its Investment Narrative?

In the past week, Brown-Forman reported quarterly results showing a 5.4% year-on-year revenue decline, with adjusted operating income roughly matching analyst expectations but EBITDA falling short. The results highlight a mixed picture in which the company’s broad spirits portfolio and brand strength continue to underpin performance despite softer top-line trends. Next, we’ll examine how this revenue decline and EBITDA miss might influence Brown-Forman’s existing investment narrative and...
NYSE:BTU
NYSE:BTUOil and Gas

Peabody Energy Stock Leads 3 US Value Picks Tied To Power Demand

With inflation running at 4.2%, a hawkish Fed chair talking about higher rates, and energy costs pushed up by geopolitical conflict, value stocks are back under the spotlight. Higher borrowing costs and pricing pressure can reshuffle which companies look attractively priced and which look stretched. This article focuses on a U.S. Value Stocks screener that filters for relatively low P/E and P/B ratios in larger, established businesses. It will walk through 3 stocks that appear positively...
NYSE:ORC
NYSE:ORCMortgage REITs

Orchid Island Capital (ORC) Expands Buyback As Higher Book Value Raises The Value Question

Orchid Island Capital (ORC) has drawn fresh attention after its Board of Directors expanded the stock repurchase program to cover about 13.3% of outstanding shares, alongside a higher estimated book value per share. See our latest analysis for Orchid Island Capital. Orchid Island Capital’s higher buyback authorization and recent dividend affirmation come as the stock trades at US$6.77, with a 1-day share price return of 2.27% and a year to date share price decline of 8.14%. The 1-year total...
NYSE:HLX
NYSE:HLXEnergy Services

How Helix’s Strengthening Value Profile and Earnings Outlook At Helix Energy Solutions Group (HLX) Has Changed Its Investment Story

Recent research highlighted Helix Energy Solutions Group's strong value characteristics, including a Zacks Rank #2 (Buy) and an A grade on value metrics, alongside comparatively attractive price-to-sales and price-to-cash-flow ratios versus industry peers. This focus on valuation has drawn increased attention from value-oriented investors, who see the combination of current pricing and a supportive earnings outlook as a potential opportunity within offshore energy services. We’ll now examine...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

IonQ Stock Leads 3 Quantum Computing Picks Worth Watching

Quantum computing stocks sit at the intersection of cutting-edge research and real-world problem solving, and that mix is attracting attention while traditional surveys and PMIs signal patchy growth, shifting rate expectations, and uneven demand across regions. The Quantum Computing Stocks screener filters this complex space for you by surfacing companies working on quantum algorithms, superconducting qubits, and related software tools. Instead of trying to track every macro headline, you can...
NasdaqCM:NN
NasdaqCM:NNSoftware

Is NextNav (NN) Cheap On Its GSMA Drone Initiative News?

NextNav (NN) is in focus after joining GSMA and industry partners in an initiative to define how mobile networks support safer and scalable drone operations through secure positioning, geolocation, and resilient low altitude connectivity. See our latest analysis for NextNav. The recent GSMA announcement comes as NextNav shares trade at US$17.13, with a 1 day share price return of 3.69% but a 30 day share price return that is down 21.21%. The 1 year total shareholder return of 14.74% and very...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Capital Clean Energy Carriers (CCEC) Enters LNG Bunkering, Is The Upside Already Priced In?

Capital Clean Energy Carriers stock reacts to new LNG bunkering joint venture Capital Clean Energy Carriers (CCEC) has drawn fresh attention after announcing a 50/50 joint venture with CMA CGM to construct, charter, and operate a 20,000 cbm dual-fuel LNG bunkering vessel. The project, priced at US$82.8 million with delivery targeted for the third quarter of 2028, is backed by an expected 12-year time charter to a CMA CGM and TotalEnergies joint venture. This highlights long-term contract...
NYSE:FLG
NYSE:FLGBanks

Interest Rates Put Lemonade Flagstar Bank And Oscar Health Stock In Focus

The passing of former Federal Reserve Chairman Alan Greenspan has pushed monetary policy back into the spotlight, with investors reassessing how interest rates, liquidity and risk appetite shape the outlook for large financial institutions. For stocks in our Financial Sector Stocks screener, this renewed focus on Fed decisions and “irrational exuberance” can influence how investors view balance sheet strength, earnings quality and valuation. This article walks through 3 stocks from that...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Is RUM Group (RUM) Undervalued Or Is Its Growth Story Already Priced In?

RUM Group (RUM) is back in focus after recent trading left the stock at a last close of US$7.36, with returns mixed over different periods and revenue far above current net income. See our latest analysis for RUM Group. Over the past year RUM Group’s share price return has swung between shorter term weakness and stronger multi month gains, with a 90 day share price return of 43.75% contrasting with a 1 year total shareholder return that declined 10.90%. If you are weighing RUM Group against...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

Ollie's Bargain Outlet (OLLI) Stock After 31% Slide Is The Pullback Enough Now

If you are wondering whether Ollie's Bargain Outlet Holdings is starting to look attractive at its current price, this article will walk through what the recent share performance and valuation checks actually say. The stock last closed at US$76.91, with the share price down 9.5% over the past week, down 6.0% over the past month and down 30.9% year to date. The 3 year return is up 27.8%, while the 5 year return is down 10.0%. Recent coverage around Ollie's Bargain Outlet Holdings has focused...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

Is Positive X-TOLE2 Epilepsy Data And 2026 FDA Filing Plan Altering The Investment Case For Xenon Pharmaceuticals (XENE)?

Xenon Pharmaceuticals recently reported highly positive Phase III X-TOLE2 results for azetukalner in focal onset seizures and has since confirmed plans to submit a new drug application to the FDA for this indication in the third quarter of 2026. This progress strengthens the company’s neuroscience-focused pipeline by advancing azetukalner toward potential commercialization in epilepsy, a core area of its long-term growth plans. We’ll now examine how the successful X-TOLE2 trial and upcoming...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA Holdings (IQV) Stock After Mixed Returns And DCF Valuation Gap

If you are wondering whether IQVIA Holdings is attractively priced or looking stretched, this article breaks down what the current share price might imply about value. The stock last closed at US$171.28, with the share price up 2.0% over the past month but down 24.0% year to date and 29.8% over five years. The 1 year return stands at 8.0% and the 3 year return shows a 20.2% decline. Recent coverage around IQVIA Holdings has focused on its role in life sciences data and clinical services, as...
NYSE:SXT
NYSE:SXTChemicals

Sensient Technologies (SXT) Stock After Strong Multi‑Year Run Are Recent Gains Justified

If you are wondering whether Sensient Technologies stock still offers value at current levels, this article focuses squarely on what the numbers say about its price. Over recent periods, the stock has recorded returns of 6.3% over 7 days, 3.8% over 30 days, 27.1% year to date, 23.3% over 1 year, 80.8% over 3 years, and 52.4% over 5 years. This naturally raises questions about how its current valuation stacks up. Recent coverage around Sensient Technologies has focused on its role in the...
NYSE:BMNR
NYSE:BMNRSoftware

Bitmine Immersion Technologies (BMNR) Nears Russell 1000 Entry And Co Founds Ethlabs

Bitmine Immersion Technologies (NYSE:BMNR) is approaching inclusion in the Russell 1000 index, which would trigger buying by index-tracking funds once finalized. The company has co founded Ethlabs, a new nonprofit research lab focused on Ethereum, with the goal of supporting institutional use of the network. Bitmine Immersion Technologies operates in the crypto infrastructure space, where institutional interest in digital assets and blockchain tooling continues to evolve. Potential...
NYSE:SGOV
NYSE:SGOVCapital Markets

US Treasury Bond ETFs Back In Focus As Fed Signals Higher Rates

With the US Federal Reserve under Kevin Warsh signaling a more hawkish stance and bond yields reacting, short term US Treasury and government bond ETFs are back in focus for investors weighing risk and income. As markets adjust to the prospect of rate hikes and a smaller, less interventionist central bank, some stocks exposed to this news may appear better positioned than others. This article walks through three positively exposed stocks from the Short-Term US Treasury and Government Bond...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

Aeluma (ALMU) Pulled Back After Strong Gains, Is The Stock Overvalued?

Aeluma stock: recent moves in context Aeluma (ALMU) shares have seen mixed recent performance, with the stock down 6.4% on the day and 7.5% over the past week, while still up over the past 3 months and year to date. For investors tracking shorter term swings alongside longer term performance, these moves raise questions about how current pricing lines up with Aeluma’s revenue of US$5.196 million and its reported net loss of US$6.004 million. See our latest analysis for Aeluma. At a share...
NYSE:DCH
NYSE:DCHAuto Components

Dauch (DCH) Faces An Undervaluation Debate, Is The Weakness A Buying Opportunity?

Dauch (DCH) has attracted investor attention after a period of share price weakness, with the stock down 8% over the past week and 12% over the past month from its recent close. See our latest analysis for Dauch. Looking beyond this recent weakness, Dauch’s 1-year total shareholder return of 35.89% contrasts with its year to date share price decline of 12.48%. This suggests momentum has cooled following a stronger prior period. If you want to see what else is moving around Dauch’s part of the...
NYSE:UGI
NYSE:UGIGas Utilities

Is UGI (UGI) Undervalued After Its Pennsylvania Rate Case Narrative?

Recent Performance Snapshot for UGI Stock UGI (UGI) has drawn attention after a mixed period for its stock, with the price recently closing at $34.72. Short term returns were positive, although the share price was down over the past month and over the past three months. See our latest analysis for UGI. Looking beyond the latest move, UGI stock shows short term share price momentum that has recently softened, with the year to date share price return down 7.73% while the 3 year total...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum (LITE) Reveals $400 Million AI Optics Backlog And Data Center Partnerships

Lumentum Holdings (NasdaqGS:LITE) highlighted an AI-focused optics backlog exceeding $400 million at a recent global conference on AI ethics and governance. Leadership outlined how optical circuit switches and co packaged optics are positioned within AI data center infrastructure build outs. The company also discussed AI data center partnerships, emphasizing collaboration with large scale customers and ecosystem players. These comments add fresh detail on Lumentum Holdings' role in AI...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Is Down 5.5% After Post-Spin Q4 Beat But Softer 2026 EPS Guidance – Has The Bull Case Changed?

FedEx reported its fiscal fourth-quarter and full-year 2026 results, with Q4 revenue rising to US$25,007 million while net income slipped to US$1,598 million, and full-year revenue increasing to US$94,720 million alongside higher annual earnings per share from continuing operations of US$18.55. The company also completed the spin-off of FedEx Freight, raised its annual dividend by 5%, and issued new guidance calling for around 11% revenue growth and diluted EPS of US$16.55 to US$17.75 for...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

The Bull Case For Bio-Techne (TECH) Could Change Following Renewed Analyst Support In A Soft Market

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...